$ATEN
A10 Networks, Inc.

2017 Q2 Form 10-Q Financial Statement

#000158080817000031 Filed on May 05, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 Q1 2016 Q1
Revenue $53.69M $60.29M $53.80M
YoY Change -6.02% 12.05% 22.23%
Cost Of Revenue $12.80M $14.74M $13.23M
YoY Change -9.92% 11.46% 22.63%
Gross Profit $41.17M $49.19M $40.58M
YoY Change -4.07% 21.23% 22.11%
Gross Profit Margin 76.69% 81.6% 75.42%
Selling, General & Admin $32.41M $33.91M $33.43M
YoY Change -4.68% 1.44% 4.31%
% of Gross Profit 78.72% 68.94% 82.38%
Research & Development $16.49M $17.04M $14.78M
YoY Change 13.83% 15.33% 3.27%
% of Gross Profit 40.05% 34.64% 36.42%
Depreciation & Amortization $1.800M $1.800M $1.900M
YoY Change 0.0% -5.26% -24.0%
% of Gross Profit 4.37% 3.66% 4.68%
Operating Expenses $48.90M $50.95M $50.00M
YoY Change 0.44% 1.91% 6.82%
Operating Profit -$7.730M -$1.761M -$9.420M
YoY Change 33.97% -81.31% -30.59%
Interest Expense $64.00K $44.00K $126.0K
YoY Change -49.21% -65.08% -0.79%
% of Operating Profit
Other Income/Expense, Net -$90.00K $798.0K $89.00K
YoY Change -110.07% 796.63% -189.0%
Pretax Income -$7.820M -$963.0K -$9.331M
YoY Change 60.38% -89.68% -31.75%
Income Tax $135.0K $374.0K $204.0K
% Of Pretax Income
Net Earnings -$7.955M -$1.337M -$9.535M
YoY Change 61.2% -85.98% -30.57%
Net Earnings / Revenue -14.82% -2.22% -17.72%
Basic Earnings Per Share -$0.11 -$0.02
Diluted Earnings Per Share -$0.11 -$0.02 -$148.3K
COMMON SHARES
Basic Shares Outstanding 69.34M shares 68.35M shares 64.31M shares
Diluted Shares Outstanding 64.31M shares

Balance Sheet

Concept 2017 Q2 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $132.2M $116.2M $107.5M
YoY Change 16.27% 8.09% 25.58%
Cash & Equivalents $46.39M $30.58M $38.20M
Short-Term Investments $85.80M $85.60M $69.30M
Other Short-Term Assets $7.300M $6.200M $6.400M
YoY Change 35.19% -3.13% 52.38%
Inventory $15.39M $16.51M $17.17M
Prepaid Expenses
Receivables $41.37M $61.84M $41.94M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $196.2M $200.7M $173.0M
YoY Change 13.56% 16.02% 6.6%
LONG-TERM ASSETS
Property, Plant & Equipment $8.266M $8.131M $8.641M
YoY Change -7.3% -5.9% -13.16%
Goodwill $1.300M $1.300M
YoY Change -0.54%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.930M $4.569M $4.119M
YoY Change 33.93% 10.92% -12.27%
Total Long-Term Assets $20.41M $20.28M $12.76M
YoY Change 3.71% 58.93% -12.88%
TOTAL ASSETS
Total Short-Term Assets $196.2M $200.7M $173.0M
Total Long-Term Assets $20.41M $20.28M $12.76M
Total Assets $216.7M $221.0M $185.8M
YoY Change 12.56% 18.97% 4.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.318M $8.522M $9.562M
YoY Change 6.89% -10.88% 19.69%
Accrued Expenses $25.40M $29.89M $24.44M
YoY Change -11.91% 22.28% 23.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $95.55M $97.19M $84.72M
YoY Change 8.59% 14.72% 24.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $794.0K $912.0K $1.285M
YoY Change -31.67% -29.03% -17.47%
Total Long-Term Liabilities $794.0K $912.0K $1.285M
YoY Change -31.67% -29.03% -17.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $95.55M $97.19M $84.72M
Total Long-Term Liabilities $794.0K $912.0K $1.285M
Total Liabilities $127.0M $132.4M $110.1M
YoY Change 11.87% 20.24% 23.67%
SHAREHOLDERS EQUITY
Retained Earnings -$255.1M -$246.9M -$231.4M
YoY Change 7.97% 6.7% 18.33%
Common Stock $1.000K $1.000K $1.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $89.64M $88.59M $75.64M
YoY Change
Total Liabilities & Shareholders Equity $216.7M $221.0M $185.8M
YoY Change 12.56% 18.97% 4.99%

Cashflow Statement

Concept 2017 Q2 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$7.955M -$1.337M -$9.535M
YoY Change 61.2% -85.98% -30.57%
Depreciation, Depletion And Amortization $1.800M $1.800M $1.900M
YoY Change 0.0% -5.26% -24.0%
Cash From Operating Activities $13.22M $545.0K $10.44M
YoY Change 49.89% -94.78% -289.85%
INVESTING ACTIVITIES
Capital Expenditures -$830.0K $678.0K $1.388M
YoY Change -30.83% -51.15% 54.05%
Acquisitions
YoY Change
Other Investing Activities -$230.0K -$300.0K -$69.32M
YoY Change -98.86% -99.57%
Cash From Investing Activities -$1.070M -$980.0K -$70.70M
YoY Change -94.99% -98.61% 7747.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.065M $370.0K
YoY Change 458.11% 478.13%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.640M $2.040M $345.0K
YoY Change 23.39% 491.3% 439.06%
NET CHANGE
Cash From Operating Activities 13.22M $545.0K $10.44M
Cash From Investing Activities -1.070M -$980.0K -$70.70M
Cash From Financing Activities 3.640M $2.040M $345.0K
Net Change In Cash 15.79M $1.605M -$59.92M
YoY Change -264.99% -102.68% 845.87%
FREE CASH FLOW
Cash From Operating Activities $13.22M $545.0K $10.44M
Capital Expenditures -$830.0K $678.0K $1.388M
Free Cash Flow $14.05M -$133.0K $9.050M
YoY Change 40.22% -101.47% -241.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 aten Availableforsale Securities Year Two Through Three Amortized Cost
AvailableforsaleSecuritiesYearTwoThroughThreeAmortizedCost
30969000 USD
CY2017Q1 aten Availableforsale Securities Year Two Through Three Fair Value
AvailableforsaleSecuritiesYearTwoThroughThreeFairValue
30938000 USD
CY2016Q1 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
215000 USD
CY2017Q1 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
842000 USD
CY2016Q1 aten Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
0 USD
CY2017Q1 aten Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
41000 USD
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001580808
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69337156 shares
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q1 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
A10 Networks, Inc.
CY2017Q1 dei Trading Symbol
TradingSymbol
ATEN
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9851000 USD
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8522000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
66755000 USD
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
61842000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31525000 USD
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29887000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41244000 USD
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42804000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45000 USD
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-46000 USD
CY2017Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P4Y5M
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
328869000 USD
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
335493000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3619000 USD
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2994000 USD
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33000 USD
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 USD
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11095000 shares
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13486000 shares
CY2016Q4 us-gaap Assets
Assets
221338000 USD
CY2017Q1 us-gaap Assets
Assets
221015000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
201309000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
200736000 USD
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
114347000 USD
CY2017Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
116175000 USD
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
85372000 USD
CY2017Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
85595000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
19000 USD
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
64000 USD
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
60000 USD
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
85417000 USD
CY2017Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
85641000 USD
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
64000 USD
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
60000 USD
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
53351000 USD
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
58922000 USD
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0 USD
CY2016Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
85372000 USD
CY2017Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
85595000 USD
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis
54672000 USD
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
54657000 USD
CY2016Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
364000 USD
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
458000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98117000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38196000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28975000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30580000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-59921000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1605000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67873000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
69265000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67873000 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69265000 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9479000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3901000 USD
CY2016Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13227000 USD
CY2017Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14144000 USD
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8698000 USD
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
9784000 USD
CY2016Q1 us-gaap Cost Of Services
CostOfServices
4529000 USD
CY2017Q1 us-gaap Cost Of Services
CostOfServices
4360000 USD
CY2016Q4 us-gaap Deferred Revenue
DeferredRevenue
92908000 USD
CY2017Q1 us-gaap Deferred Revenue
DeferredRevenue
93105000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
61334000 USD
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
58780000 USD
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
31574000 USD
CY2017Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
34325000 USD
CY2016Q1 us-gaap Depreciation
Depreciation
1900000 USD
CY2017Q1 us-gaap Depreciation
Depreciation
1800000 USD
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1906000 USD
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2202000 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22326000 USD
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20852000 USD
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
40200000 USD
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M7D
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1353000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1714000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1082000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
864000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1442000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1442000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1442000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7986000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7986000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6633000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6272000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3526000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
204000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6661000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7161000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
1300000 USD
CY2017Q1 us-gaap Goodwill
Goodwill
1300000 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
40577000 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
46142000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9331000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
374000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-824000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1624000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15641000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5214000 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3351000 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1647000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2039000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
197000 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-772000 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2222000 USD
CY2016Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-69000 USD
CY2017Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
14000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1167000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1699000 USD
CY2016Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
7940000 USD
CY2017Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
7579000 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
126000 USD
CY2017Q1 us-gaap Interest Expense
InterestExpense
44000 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8401000 USD
CY2017Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9130000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
15070000 USD
CY2017Q1 us-gaap Inventory Net
InventoryNet
16509000 USD
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6669000 USD
CY2017Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7379000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
135272000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
132426000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
221338000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
221015000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
102710000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
97189000 USD
CY2016Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1791000 USD
CY2017Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
345000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2040000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70704000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-980000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
988000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10438000 USD
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
56000 USD
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
545000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-9535000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-3900000 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9535000 USD
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3900000 USD
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
89000 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
798000 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
49997000 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
50466000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9420000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4324000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5859000 USD
CY2017Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6141000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3870000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4569000 USD
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
912000 USD
CY2016Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-276000 USD
CY2017Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
278000 USD
CY2016Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
69530000 USD
CY2017Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
18616000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1388000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
678000 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5137000 USD
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6210000 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
370000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2065000 USD
CY2016Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-25000 USD
CY2017Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-25000 USD
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
214000 USD
CY2017Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
18314000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49463000 USD
CY2017Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
50935000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8219000 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8131000 USD
CY2016Q1 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
345000 USD
CY2017Q1 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
783000 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14777000 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17042000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-242759000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-246859000 USD
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
36374000 USD
CY2017Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
39706000 USD
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
53804000 USD
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
60286000 USD
CY2016Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
17430000 USD
CY2017Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
20580000 USD
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26768000 USD
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26263000 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4612000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4316000 USD
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
421000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4708000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
120000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.38
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
30187000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7868000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7020000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.82
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.00
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
23268000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5247000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
4.87
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.84
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.82
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.00
CY2017Q1 us-gaap Share Price
SharePrice
9.15
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
56249000 USD
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M12D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y7M6D
CY2016Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
1603000 USD
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
728000 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
86066000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
88589000 USD
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3340000 USD
CY2017Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
2894000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3300000 USD
CY2017Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3400000 USD
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
64309000 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68571000 shares
CY2017Q1 us-gaap Year Founded
YearFounded
2004
CY2017Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents, marketable securities and accounts receivable. Our cash and marketable securities are held and invested in high-credit quality financial instruments by recognized financial institutions and therefore subject to minimum credit risk.<br clear="none"/> <br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our accounts receivable are&#160;unsecured and represent amounts due to us based on contractual obligations of our customers. We mitigate credit risk in respect to accounts receivable by performing periodic credit evaluations based on a number of factors, including past transaction experience, evaluation of credit history and review of the invoicing terms of the contract. We generally do not require our customers to provide collateral to support accounts receivable.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant&#160;customers, including distribution channel partners and direct customers, are those which represent more than 10% of our total revenue for each period presented or our gross accounts receivable balance as of each respective balance sheet date. R</font></div></div>
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Those estimates and assumptions affect revenue recognition and deferred revenue, allowance for doubtful accounts, sales return reserve, valuation of inventory, fair value of marketable securities, contingencies and litigation, acquisition related purchase price allocations, accrued liabilities, and the determination of fair value of stock-based compensation. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from management&#8217;s estimates.</font></div></div>

Files In Submission

Name View Source Status
0001580808-17-000031-index-headers.html Edgar Link pending
0001580808-17-000031-index.html Edgar Link pending
0001580808-17-000031.txt Edgar Link pending
0001580808-17-000031-xbrl.zip Edgar Link pending
a10-q3312017.htm Edgar Link pending
aten-20170331.xml Edgar Link completed
aten-20170331.xsd Edgar Link pending
aten-20170331_cal.xml Edgar Link unprocessable
aten-20170331_def.xml Edgar Link unprocessable
aten-20170331_lab.xml Edgar Link unprocessable
aten-20170331_pre.xml Edgar Link unprocessable
exhibit1013312017.htm Edgar Link pending
exhibit3113312017.htm Edgar Link pending
exhibit3123312017.htm Edgar Link pending
exhibit3213312017.htm Edgar Link pending
exhibit3223312017.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending